What is NDC 0143-9935?

0143-9935 is the product NDC for Cefotaxime, Cefotaxime sodium 10 g/1 injection, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefotaxime?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefotaxime NDC 0143-9935 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9935Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9935Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9935-01	0014399350100143993501	1 INJECTION in 1 PACKAGE (0143-9935-01)Marketed from Nov 20, 2002

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefotaxime
Generic name (nonproprietary): cefotaxime
Active ingredients: Cefotaxime sodium — 10 g/1
Dosage form: Injection
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065071
Marketing start: Nov 20, 2002
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0143-9935_e25af43f-54cb-4526-a8a5-6bef0a7939c7SPL ID e25af43f-54cb-4526-a8a5-6bef0a7939c7SPL set ID ef1a6dc6-bc3d-4f09-8f92-7ff328f56561RxCUI 309065UNII 258J72S7TZ
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143993501 followed by a unit qualifier and the quantity

Package 00143-9935-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 11, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Treatment Cefotaxime for Injection, USP is indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) Lower respiratory tract infections, including pneumonia, caused by Streptococcus pneumoniae (formerly Diplococcus pneumoniae ), Streptococcus pyogenes* (Group A streptococci) and other streptococci (excluding enterococci, e.g., Enterococcus faecalis ), Staphylococcus aureus (penicillinase and non-penicillinase producing), Escherichia coli , Klebsiella species, Haemophilus influenzae (including ampicillin resistant strains), Haemophilus parainfluenzae , Proteus mirabilis…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9935

What is NDC 0143-9935?: 0143-9935 is the product NDC for Cefotaxime, Cefotaxime sodium 10 g/1 injection, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cefotaxime.
What is the active ingredient?: Cefotaxime sodium.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefotaxime?: 5 other product NDCs are listed under this name. See all Cefotaxime NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefotaxime NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefotaximecefotaxime injection	Cefotaxime sodium 1 g/1	Powder, For solutionIntramuscular, Intravenous	SteriMax Inc.	21586-011	21586-0011-02
Cefotaximecefotaxime injection	Cefotaxime sodium 2 g/1	Powder, For solutionIntramuscular, Intravenous	SteriMax Inc.	21586-012	21586-0012-02
Cefotaxime	Cefotaxime sodium 500 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9930	00143-9930-10
Cefotaxime	Cefotaxime sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9931	00143-9931-25
Cefotaxime	Cefotaxime sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9933	00143-9933-25